Related Experiment Video
Updated: May 19, 2026
05:50
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Piperidin-4-one: the potential pharmacophore.
Shashi Kant Sahu1, Bidhyut Kumar Dubey, Avinash C Tripathi
1Babu Banarasi Das Northern India Institute of Technology, BBD City, Faizabad Road, Lucknow, U.P., India.
Mini Reviews in Medicinal Chemistry
|August 11, 2012
Summary
Piperidin-4-ones are key building blocks in medicinal chemistry, offering diverse pharmacological activities like anticancer and anti-HIV effects. Recent research focuses on novel synthesis, stereochemistry, and biological applications of these versatile compounds.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Piperidin-4-ones are recognized as versatile chemical intermediates.
- These compounds exhibit significant pharmacological properties, including anticancer and anti-HIV activities.
- Modification of the piperidin-4-one scaffold enhances receptor interactions and biological efficacy.
Purpose of the Study:
- To review current research trends in piperidin-4-one chemistry.
- To cover synthetic protocols, characterization, and stereochemistry.
- To highlight important biological activities reported in the last decade.
Main Methods:
- Exploration of various synthetic strategies, including Mannich reactions and stereoselective synthesis.
- Analysis of characterization techniques for piperidin-4-one derivatives.
- Review of stereochemical considerations in synthesis and activity.
Main Results:
- Documented diverse synthetic routes for piperidin-4-ones.
- Summarized key pharmacological activities, emphasizing anticancer and anti-HIV potential.
- Highlighted the importance of structural modifications for improved biological outcomes.
Conclusions:
- Piperidin-4-ones remain crucial in medicinal chemistry due to their synthetic accessibility and broad biological relevance.
- Continued research into their synthesis and modification is vital for drug discovery.
- The last decade has shown significant advancements in understanding and utilizing piperidin-4-ones.
Related Concept Videos
01:25Basicity of Heterocyclic Aromatic Amines
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:18Aromatic Hydrocarbon Anions: Structural Overview
Neutral hydrocarbons like cyclopentadiene with an odd number of carbon atoms and one intervening CH2 group in the ring are not aromatic. Cyclopentadiene with 4 π electrons does not satisfy the 4n + 2 π electron rule. Additionally, the intervening CH2 group is sp3 hybridized and lacks a vacant p orbital, thereby interrupting the overlap of p orbitals in a continuous manner and preventing the delocalization of π electrons throughout the ring.
Due to the absence of continuous overlap of p...
Due to the absence of continuous overlap of p...
01:20Criteria for Aromaticity and the Hückel 4n + 2 Rule
Like benzene, cyclobutadiene and cyclooctatetraene are cyclic compounds with alternate single and double bonds. However, their chemical behavior differs from benzene, as they are unstable and not aromatic. So, what are the structural characteristics of unsaturated compounds categorized as aromatic?
For the first time, Eric Hückel, a German chemical physicist, derived a set of structural features for a compound to be classified as aromatic. This is now known as Hückel’s rule or the 4n + 2 rule.
For the first time, Eric Hückel, a German chemical physicist, derived a set of structural features for a compound to be classified as aromatic. This is now known as Hückel’s rule or the 4n + 2 rule.